Leadership & Pay ·
Pays $1.3M severance to former CIO Brian Donnelly under separation agreement
MYGNMyriad Genetics Inc
Myriad Genetics entered into a Separation Agreement with Brian Donnelly, its former Chief Commercial Officer, who departed effective September 16, 2026. The company will pay a lump sum of $1,322,294 upon the agreement's effectiveness on October 14, 2026, contingent on compliance with restrictive covenants and release of claims. Additionally, time-based equity awards scheduled to vest within two years post-separation are accelerated into monthly installments, while performance-based awards remain outstanding subject to their original conditions. Myriad Genetics operates in the healthcare sector, specializing in genetic testing and diagnostics.